Gabelli Funds LLC boosted its stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 7.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 563,100 shares of the company's stock after acquiring an additional 38,458 shares during the quarter. Gabelli Funds LLC owned 0.33% of Option Care Health worth $13,064,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in OPCH. Murphy & Mullick Capital Management Corp purchased a new stake in shares of Option Care Health during the fourth quarter worth approximately $26,000. UMB Bank n.a. boosted its holdings in shares of Option Care Health by 41.7% during the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock worth $27,000 after purchasing an additional 346 shares during the last quarter. Signaturefd LLC grew its position in shares of Option Care Health by 487.9% in the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company's stock valued at $28,000 after purchasing an additional 1,005 shares in the last quarter. Quadrant Capital Group LLC increased its holdings in shares of Option Care Health by 172.8% in the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock valued at $40,000 after purchasing an additional 1,099 shares during the last quarter. Finally, Sterling Capital Management LLC boosted its stake in Option Care Health by 638.5% during the fourth quarter. Sterling Capital Management LLC now owns 2,954 shares of the company's stock worth $69,000 after buying an additional 2,554 shares during the last quarter. Hedge funds and other institutional investors own 98.05% of the company's stock.
Insider Buying and Selling
In related news, insider Michael Bavaro sold 30,996 shares of the business's stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the sale, the insider now owns 44,974 shares in the company, valued at $1,495,835.24. The trade was a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.64% of the company's stock.
Option Care Health Stock Up 1.1 %
Shares of Option Care Health stock traded up $0.36 on Tuesday, reaching $31.61. 178,740 shares of the company were exchanged, compared to its average volume of 1,789,242. The stock's 50 day moving average price is $33.32 and its 200-day moving average price is $28.66. The company has a market cap of $5.19 billion, a P/E ratio of 26.61, a price-to-earnings-growth ratio of 2.30 and a beta of 1.07. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $35.53. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32.
Analysts Set New Price Targets
A number of brokerages recently issued reports on OPCH. JPMorgan Chase & Co. upped their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a report on Thursday, March 6th. Jefferies Financial Group upgraded Option Care Health from a "hold" rating to a "buy" rating and increased their price target for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. JMP Securities reaffirmed a "market outperform" rating and issued a $36.00 target price on shares of Option Care Health in a research report on Tuesday. Barrington Research reissued an "outperform" rating and issued a $38.00 price target on shares of Option Care Health in a research note on Monday. Finally, Bank of America raised shares of Option Care Health from a "neutral" rating to a "buy" rating and increased their price objective for the stock from $26.00 to $33.00 in a research report on Monday, January 13th. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $33.75.
Check Out Our Latest Report on OPCH
Option Care Health Company Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Featured Stories
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
